| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Tuberculosis | D014376 | 20 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Adenoma, Islet Cell | D007516 | 7 associated lipids |
CYTOCHALASIN B
CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.
Cross Reference
Introduction
To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with CYTOCHALASIN B?
CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B
PubChem Associated disorders and diseases
What pathways are associated with CYTOCHALASIN B
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with CYTOCHALASIN B?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with CYTOCHALASIN B?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with CYTOCHALASIN B?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with CYTOCHALASIN B?
Related references are published most in these journals:
- Am. J. Physiol., Cell Physiol. (2)
- Am. J. Physiol. Endocrinol. Metab. (1)
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Others (8)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with CYTOCHALASIN B?
Xenograft Model
Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with CYTOCHALASIN B
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Dularay B et al. | Oxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis. | 1990 | Ann. Rheum. Dis. | pmid:2173500 |
| Gu YJ et al. | Increased neutrophil priming and sensitization before commencing cardiopulmonary bypass in cardiac surgical patients. | 2002 | Ann. Thorac. Surg. | pmid:12400764 |
| Samson FE | Pharmacology of drugs that affect intracellular movement. | 1976 | Annu. Rev. Pharmacol. Toxicol. | pmid:938015 |
| Zimmerman TJ et al. | Advances in ocular pharmacology. | 1980 | Annu. Rev. Pharmacol. Toxicol. | pmid:6155823 |
| Feurer C and Borel JF | Localised leukocyte moblisation in the rabbit ear. An in vivo cell migration technique using plastic collection chambers. | 1974 | Antibiot Chemother (1971) | pmid:4463828 |
| Castiglione S et al. | Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions. | 1993 | Anticancer Drugs | pmid:8358069 |
| Trendowski M et al. | The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells. | 2014 | Anticancer Res. | pmid:24778021 |
| Baatout S et al. | Inhibition of actin polymerization by cytochalasin B induces polyploidization and increases the number of nucleolar organizer regions in human megakaryocyte cell lines. | 1998 Jan-Feb | Anticancer Res. | pmid:9568120 |
| Trendowski M et al. | Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents. | 2015 | Anticancer Res. | pmid:25550536 |
| Baatout S et al. | Interaction between protein kinase C and actin in megakaryocyte polyploidization. | 1999 Sep-Oct | Anticancer Res. | pmid:10628374 |
| Aston R and Ayad SR | Cyclic AMP mediated morphological changes in a hybrid cell line. | 1981 | Anticancer Res. | pmid:6287905 |
| Bracke ME et al. | Action mechanisms of anti-invasive agents. | 1986 Nov-Dec | Anticancer Res. | pmid:3813483 |
| Walters JD et al. | Mechanisms of fluoroquinolone transport by human neutrophils. | 1999 | Antimicrob. Agents Chemother. | pmid:10543751 |
| Okuda K | Effects of cytochalasin B on the intrcellular bactericidal activity of human neutrophils. | 1975 | Antimicrob. Agents Chemother. | pmid:1155917 |
| Mandell LA and Afnan M | Mechanisms of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophils, and gram-negative bacilli. | 1991 | Antimicrob. Agents Chemother. | pmid:1929284 |
| Henderson PJ et al. | Dissection of discrete kinetic events in the binding of antibiotics and substrates to the galactose-H+ symport protein, GalP, of Escherichia coli. | 1994 | Antonie Van Leeuwenhoek | pmid:7832591 |
| Esposito AL et al. | An assessment of the factors contributing to the killing of type 3 Streptococcus pneumoniae by human polymorphonuclear leukocytes in vitro. | 1990 | APMIS | pmid:2405890 |
| Lock R and Dahlgren C | Characteristics of the granulocyte chemiluminescence reaction following an interaction between human neutrophils and Salmonella typhimurium bacteria. | 1988 | APMIS | pmid:3285865 |
| Sompolinsky D and Richmond S | Growth of Chlamydia trachomatis in McCoy cells treated with cytochalasin B. | 1974 | Appl Microbiol | pmid:4451373 |
| Ruch JV et al. | [Effects of cytochalasin B and colchicine on dental cytodifferentiation in vitro]. | 1975 Apr-Jun | Arch Anat Microsc Morphol Exp | pmid:1217902 |